Fundz

Element Biosciences Closes Acquisition Of Loop Genomics

PRIVATEFeb 08, 2022

Acquiring Company

Element Biosciences

Acquired Company

Loop Genomics

San DiegoBiotechnologyHealth CareGeneticsLife ScienceBiotechnologyHealth CareScience And EngineeringAgriculture And Farming

Description

Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long range information. Loop Genomics’ Chief Executive Officer and Founder, Tuval Ben-Yehezkel, PhD, will join Element Biosciences’ leadership team as Senior Director, Applications.

Quick answer

Element Biosciences is acquiring Loop Genomics, announced February 8, 2022. Element Biosciences is based in San Diego, California, United States.

How much did Element Biosciences pay for Loop Genomics?
The deal value was not disclosed.
What does Element Biosciences do?
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Where are Element Biosciences and Loop Genomics based?
Element Biosciences is based in San Diego, California, United States.
Who are the decision-makers at Element Biosciences?
Fundz holds 1 contact at Element Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Genetics and Life Science

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Element Biosciences, and when

When Element Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Element Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Element Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Element Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Element Biosciences

Location

San Diego, California, United States

About

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high-quality data, increase workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease run costs and capital costs while delivering high sequencing data quality.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Element Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Yaron
Likely contact at this company
••••••••@••••••••

See Yaron's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Element Biosciences's next move

Learn about Strategic plan

Frequently asked

Who acquired Loop Genomics?

Loop Genomics was acquired by Element Biosciences, based in San Diego. The deal was reported on February 8, 2022. Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. Element Biosciences is privately held and operates in Biotechnology.

When did Element Biosciences acquire Loop Genomics?

Element Biosciences's acquisition of Loop Genomics was reported on February 8, 2022. Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long range information. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Loop Genomics do?

Loop Genomics is a synthetic long-read sequencing company developing and commercializing products in a wide variety of genetic analysis applications, including among others, genome, transcriptome, microbiome, and immune repertoire sequencing. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.